Delivered by MTPConnect, the Australian Government's $45 million BioMedTech Horizons program (BMTH), is a Medical Research Future Fund (MRFF) initiative to support innovative collaborative health technologies, drive discoveries towards proof-of-concept and commercialisation that address key health challenges as well as maximise entrepreneurship and idea potential.
Across four funding rounds, the BMTH program has funded 49 projects and investments from the program have focused on supporting proof-of-concept to commercial development of biomedical and medical technologies.
New Report Reveals Investors Back Homegrown Future Medical Devices After MRFF Funding
As the second phase of the BioMedTech Horizons (BMTH) program moves to completion, a new report has captured the outcomes of 38 innovations supported through the program.
Launched in May 2017, the BMTH program is an initiative of the Medical Research Future Fund (MRFF) designed and delivered by MTPConnect to support early-stage medical device developments to move towards commercialisation.
The impact report covers the second, third and fourth rounds of BMTH which saw $30.3 million in funding awarded, leveraging an additional $36 million in contributions from industry.
This Australian government investment has supported 306 jobs, 87 medical technologies have been progressed toward commercialisation, 27 human clinical studies and trials have been initiated or completed, and eight technologies have received marketing approval and are commercialised.
Read all 38 case studies and find out more about these innovative BMTH projects and their impact on the MTP sector:
First Projects to Complete BioMedTech Horizons Program Deliver Outstanding Research and Commercial Outcomes
Through a series of case studies, a new impact report has been launched highlighting the progress of the first cohort of projects to complete the BioMedTech Horizons (BMTH) program. The first round – BMTH1 - opened in 2017 and focused on precision medicine and 3D anatomical printing.
Of the 11 projects identified and funded as part of BMTH1, nine successfully completed their program of works, advancing their devices toward research and commercialisation objectives.
The BMTH program has a focus on commercial outcomes, supporting projects to reach the proof-of-concept stage and beyond so they are attractive for private capital or third-party investment. By this measure, the projects funded through BMTH1 have been an outstanding success with 72 commercial outcomes realised and 58 new jobs created.
Track the progress of our BMTH Projects via our Health Horizon BMTH Projects Tracker LIVE Feed – find out projects’ current status in real time.
- Ep 137: Inventia’s Skin Printing Robot Revolutionising Wound Repair
- Ep 124: ARIA Research: bionic glasses giving vision via sound
- Ep 108: Synchron's Breakthrough Brain-Computer Interface Helping Treat Paralysis
- Ep 99: Artrya
- Ep 61: WearOptimo
- Ep 37: BMTH Value-Add Day
- Ep 20: Bionics Institute
BMTH Case Studies:
- BMTH: Kicking Goals in Collingwood - ZiP Diagnostics Australian-made Point of Care Tests for Infectious Diseases
- Ingestible Capsule set to Revolutionise Gut Health Diagnosis
- Garvan creates Australia’s First Cancer Genomics Testing Service and Secures SydPath Deal
- East Meets West - The Chemistry of a Perfect Match for SpeeDx and SynGenis
- Silk-based implants set to revolutionise the treatment of chronic middle ear disease
- Artrya Is On The Pulse
- Driving Australia's Medtech Manufacturing for Patients Recovering from Brain Surgery
- OncoRes Medical Helps Get Surgeons In Touch